Bejr-kasem, H, Martinez-Horta, S, Pagonabarraga, J, Marin-Lahoz, J, Horta-Barba, A, Sampedro, F, Aracil-Bolanos, I, Perez-Perez, J, Campolongo, A, Izquierdo, C, Pascual-Sedano, B, Kulisevsky, J. The role of attentional control over interference in minor hallucinations in Parkinson's disease. PARKINSONISM & RELATED DISORDERS. 2022; 102DOI:10.1016/j.parkreldis.2022.07.009. PMID:35987038. IF:4.100(Q2/3D).

Calabria, M, Garcia-Sanchez, C, Grunden, N, Pons, C, Arroyo, JA, Gomez-Anson, B, Garcia, MDE, Belvis, R, Morollon, N, Igual, JV, Mur, I, Pomar, V, Domingo, P. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. JOURNAL OF NEUROLOGY. 2022; 269(8)DOI:10.1007/s00415-022-11141-8. PMID:35488918. IF:6.000(Q1/2D).

Sampedro F., Martínez-Horta S., Kulisevsky J.. Response to letter: "Association of elevated blood homocysteine with cognitive decline in early, untreated Parkinson's disease". JOURNAL OF THE NEUROLOGICAL SCIENCES. 2022; 438DOI:10.1016/j.jns.2022.120272. PMID:35576640. IF:4.400(Q2/3D).

Kulisevsky, J, Martinez-Horta, S, Campolongo, A, Pascual-Sedano, B, Marin-Lahoz, J, Bejr-kasem, H, Aracil-Bolanos, I, Horta-Barba, A, Puig-Davi, A, Pagonabarraga, J. A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.866502. PMID:35720066. IF:3.400(Q2/5D).

Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Alvarado, MCI, Panceiras, MJF, Castro, ES, Canfield, H, Miro, CM, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, DiazL, LML, McAfee, D, Martinez-Martin, P, Mir, P. Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson's disease patients. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2022; 37(6)DOI:10.1002/gps.5761. PMID:35633051. IF:4.000(Q2/3D).

Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Castro, ES, Canfield, H, Miro, CM, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Hernandez-Vara, J, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P. Motor Fluctuations Development Is Associated with Non-Motor Symptoms Burden Progression in Parkinson's Disease Patients: A 2-Year Follow-Up Study. Diagnostics. 2022; 12(5)DOI:10.3390/diagnostics12051147. PMID:35626303. IF:3.600(Q2/4D).

Sampedro, F, Martinez-Horta, S, Horta-Barba, A, Grothe, MJ, Labrador-Espinosa, MA, Jesus, S, Adarmes-Gomez, A, Carrillo, F, Puig-Davi, A, Lora, FR, Barbera, MA, Pastor, P, Arroyo, SE, Vila, BS, Foraster, AC, Martinez, JR, Padilla, FC, Morlans, MP, Aramburu, IG, Ceberio, JI, Vara, JH, de Fabregues-Boixar, O, de Deus Fonticoba, T, Avila, A, Martinez-Castrillo, JC, Bejr-Kasem, H, Campolongo, A, Pascual-Sedano, B, Martinez-Martin, P, Santos-Garcia, D, Mir, P, Kulisevsky, J. Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease. JOURNAL OF THE NEUROLOGICAL SCIENCES. 2022; 434DOI:10.1016/j.jns.2022.120148. PMID:35085959. IF:4.400(Q2/3D).

Sampedro, F, Martinez-Horta, S, Marin-Lahoz, J, Pagonabarraga, J, Kulisevsky, J. Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson's Disease. Journal of Parkinsons Disease. 2022; 12(5)DOI:10.3233/JPD-223223. PMID:35491803. IF:5.200(Q1/3D).

Abbruzzese, G, Kulisevsky, J, Bergmans, B, Gomez-Esteban, JC, Kagi, G, Raw, J, Stefani, A, Warnecke, T, Jost, WH. A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial (vol 11, pg 187, 2021). Journal of Parkinsons Disease. 2022; 12(1)DOI:10.3233/JPD-219007. PMID:34275911. IF:5.200(Q1/3D).

Bojtos, L, Rodríguez-Antigüedad, J, Pagonabarraga, J, Martínez-Horta, S, Kulisevsky, J. Fatigue and neuropsychiatric symptoms in Parkinson's disease: a narrative review. Frontiers in Neurology. 2025; 16DOI:10.3389/fneur.2025.1670644. PMID:41211291. IF:2.800(Q2/5D).

de la Riva, P, Rodríguez-Antigüedad, J, Marta-Enguita, J, Gómez, V, Arenaza, G, Gorostidi, A, Díez, N, de Arce, A, Garmendia, E, Zumeta, E, Larrea, JA, Bergareche, A, Arregui, ALD. The role of endothelial dysfunction in the age-related poor prognosis of stroke patients undergoing endovascular treatment. Journal of Stroke & Cerebrovascular Diseases. 2025; 34(10)DOI:10.1016/j.jstrokecerebrovasdis.2025.108412. PMID:40769286. IF:1.800(Q3/7D).

Lopes, S, Fonseca, V, Pascual-Sedano, B, Simoes, R, Varanda, S, Pagonabarraga, J, Campolongo, A, Rodrigues, M. Correspondence to: Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy. PARKINSONISM & RELATED DISORDERS. 2025; 138DOI:10.1016/j.parkreldis.2025.107966. PMID:40763399. IF:3.400(Q2/3D).

Di Franco, N, de Tena, IB, Sanchez-Ruiz, A, Pereda-Velarde, A, Enfedaque, F, Gónzalez-Arias, C, Rio, LMM, Bortolozzi, A, Rodriguez-Puertas, R, Costas-Insua, C, Molina-Porcel, L, Vazquez-Oliver, A, Ozaita, A, Guzmán, M, Perea, G, Ginés, S. Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models. Translational Neurodegeneration. 2025; 14(1)DOI:10.1186/s40035-025-00500-w. PMID:40855505. IF:15.200(Q1/1D).

Rodríguez-Molinero, A, Pérez-López, C, Caballol, N, Buongiorno, M, Rivera, MAA, Ariztegui, NL, López-Manzanares, L, Hernández-Vara, J, Bayes-Rusiñol, A, Carreró, AG, Saúco, MA, Gomez, EF, Pérez-Martínez, DA, Arroyo, SE, Martí-Martínez, S, Mir, P, Juan, JMS, Martínez-Castrillo, JC, Tebé, C. Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial. npj Parkinsons Disease. 2025; 11(1)DOI:10.1038/s41531-025-00977-2. PMID:40835832. IF:8.200(Q1/1D).

Olmedo-Saura, G, Iruzubieta, P, Bernal, S, Gonzalez-Quereda, L, Pont-Sunyer, C, Navalpotro-Gómez, I, Guisado-Alonso, D, García-Sanchez, C, Rodriguez-Santiago, B, Brais, B, Pagonabarraga, J, Kulisevsky, J, Pérez-Pérez, J. Expanding the clinical-radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign. JOURNAL OF NEUROLOGY. 2025; 272(9)DOI:10.1007/s00415-025-13316-5. PMID:40788501. IF:4.600(Q1/2D).

Rodriguez-Antiguedad, J, Puig-Davi, A, Ruíz-Barrio, I, Pagonabarraga, J, Vázquez-Oliver, A, Horta-Barba, A, Kulisevsky, J, Martínez-Horta, S. CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline. Annals of Clinical and Translational Neurology. 2025; 12(8)DOI:10.1002/acn3.70075. PMID:40501082. IF:3.900(Q1/3D).

Escamilla, S, Pérez-González, R, Márquez-Marco, C, Camporesi, E, Brinkmalm, G, Padovani, A, Pilotto, A, Tolassi, C, Arici, D, Volonghi, I, Zetterberg, H, Blennow, K, Pérez-Pérez, J, Kulisevsky, J, Cuchillo-Ibáñez, I, Sáez-Valero, J. Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders. JOURNAL OF NEUROCHEMISTRY. 2025; 169(8)DOI:10.1111/jnc.70192. PMID:40823742. IF:4.000(Q2/3D).

Fortea, JI, Alvarado-Tapias, E, Simbrunner, B, Ezcurra, I, Hernández-Gea, V, Aracil, C, Llop, E, Puente, A, Roig, C, Reiberger, T, García-Pagan, JC, Calleja, JL, Ferrero-Gregori, A, Mandorfer, M, Villanueva, C, Crespo, J. Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis. JOURNAL OF HEPATOLOGY. 2025; 83(1)DOI:10.1016/j.jhep.2024.12.017. PMID:39701300. IF:33.000(Q1/1D).

Olmedo-Saura, G, Bernardi, E, Bojtos, L, Martínez-Horta, S, Pagonabarraga, J, Kulisevsky, J, Pérez-Pérez, J. Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(13)DOI:10.3390/ijms26136220. PMID:40650011. IF:4.900(Q1/3D).

Santos-García, D, Fonticoba, TD, Jesús, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, García-Soto, JD, Borrué, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Pareés, I, Alonso, PS, Losada, MGA, Ariztegui, NL, Gastón, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Ordás, C, Menendez-González, M, Mcafee, D, Martinez-Martin, P, Mir, P. Dysphagia in Parkinsons disease. A 5-year follow-up study. NEUROLOGICAL SCIENCES. 2025; 46(6)DOI:10.1007/s10072-025-08027-8. PMID:39969751. IF:2.400(Q3/6D).

Puig-Davi, A, Franch-Marti, C, Ruiz-Barrio, I, Sampedro, F, Perez-Perez, J, Matias-Guiu, JA, Cuetos, F, Olmedo-Saura, G, Perez-Carasol, L, Horta-Barba, A, Aracil-Bolanos, I, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's Disease. Annals of Clinical and Translational Neurology. 2025; 12(6)DOI:10.1002/acn3.70022. PMID:40244831. IF:3.900(Q1/3D).

Rodriguez-Antiguedad, J, Rajalingam, R, Krüger, C, Teixeira-dos-Santos, D, Sun, CSE, Fernandez-Toledo, E, Duarte, A, Saffie-Awad, P, Barrett, MJ, Flanigan, JL, Emamikhah, M, Patel, N, San Luciano, M, Cooper, C, Bahr, N, Oguh, O, Buhrmann, A, Vater, M, Fuchshofen, R, Vulinovic, F, Parreidt, MI, Weissbach, A, Lohmann, K, Klein, C, Marras, C, Camargos, S. Genotype-Phenotype Relations for the Dystonia-Parkinsonism Genes GLB1, SLC6A3, SLC30A10, SLC39A14, and PLA2G6: MDSGene Systematic Review. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(9)DOI:10.3390/ijms26094074. PMID:40362326. IF:4.900(Q1/3D).

Pérez-López, C, Caballol, N, Buongiorno, M, Rivera, MAA, Ariztegui, NL, López-Manzanares, L, Hernández-Vara, J, Rusiñol, AB, Carreró, AG, Saúco, MA, Gomez, EF, Pérez-Martínez, DA, Arroyo, SE, Martínez, SM, Mir, P, Juan, JMS, Martínez-Castrillo, JC, Rodríguez-Molinero, A. Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease. Clinical Parkinsonism & Related Disorders. 2025; 12DOI:10.1016/j.prdoa.2025.100325. PMID:40329979. IF:(Q/D).

Martinez-Horta S., Perez-Perez J., Kulisevsky J.. Koro-like syndrome in Huntington's disease. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2025; 18(1)DOI:10.1016/j.rpsm.2023.01.006. PMID:37852879. IF:2.800(Q/D).

Moreu-Valls, A, Puig-Davi, A, Martinez-Horta, S, Kulisevsky, G, Sampedro, F, Perez-Perez, J, Horta-Barba, A, Olmedo-Saura, G, Pagonabarraga, J, Kulisevsky, J. A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington's disease. JOURNAL OF NEUROLOGY. 2025; 272(3)DOI:10.1007/s00415-025-12927-2. PMID:39934473. IF:4.600(Q1/2D).

Pérez-Pérez, J, García-López, S, Valle, TF, Painous, C, Querol-Pascual, MR, Ruiz, PJG, Diago, EB, Delgado, EC, Pastor, BV, Villaplana, MCP, Santana, IM, Estrada, MB, Garride, MC, Mir, P, Alvarez, C, Maurino, J, de Prado, A, López-Sendón, JL. Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective (Nov, 10.1007/s40120-024-00655-0, 2024). Neurology and Therapy. 2025; 14(1)DOI:10.1007/s40120-024-00683-w. PMID:39570476. IF:4.800(Q1/2D).

Pérez-Pérez, J, García-López, S, Valle, TF, Painous, C, Querol-Pascual, MR, Ruiz, PJG, Diago, EB, Delgado, EC, Pastor, BV, Villaplana, MCP, Santana, IM, Estrada, MB, Garride, MC, Ribera, PM, Alvarez, C, Maurino, J, de Prado, A, López-Sendón, JL. Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective. Neurology and Therapy. 2025; 14(1)DOI:10.1007/s40120-024-00655-0. PMID:39370480. IF:4.800(Q1/2D).

Cattaneo, C, Pagonabarraga, J. Sex Differences in Parkinson's Disease: A Narrative Review. Neurology and Therapy. 2025; 14(1)DOI:10.1007/s40120-024-00687-6. PMID:39630386. IF:4.800(Q1/2D).

Rodríguez-Antigüedad, J, Olmedo-Saura, G, Pagonabarraga, J, Martínez-Horta, S, Kulisevsky, J. Approaches for treating neuropsychiatric symptoms in Parkinson's disease: a narrative review. Therapeutic Advances in Neurological Disorders. 2025; 18DOI:10.1177/17562864251336903. PMID:40433403. IF:4.100(Q1/2D).

Berzosa-Gonzalez, I, Martinez-Horta, S, Pérez-Pérez, J, Kulisevsky, J, Pagonabarraga, J. Therapeutic Approach to Primary Tic Disorders and Associated Psychiatric Comorbidities. Brain Sciences. 2024; 14(12)DOI:10.3390/brainsci14121231. PMID:39766430. IF:2.800(Q3/6D).

Gonzalez-Herrero, B, Happé, F, Nicholson, TR, Morgante, F, Pagonabarraga, J, Deeley, Q, Edwards, MJ. Functional Neurological Disorder and Autism Spectrum Disorder: A Complex and Potentially Significant Relationship. Brain and Behavior. 2024; 14(12)DOI:10.1002/brb3.70168. PMID:39705515. IF:2.700(Q2/3D).

Salvat-Rovira, N, Vazquez-Oliver, A, Rivas-Asensio, E, Herrero-Lorenzo, M, Gámez-Valero, A, Pérez-Pérez, J, Izquierdo, C, Campolongo, A, Marti, E, Kulisevsky, J, Pérez-González, R. Methodological Assessment of ExoGAG for Isolation of Cerebrospinal Fluid Extracellular Vesicles as a Source of Biomarkers. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(24)DOI:10.3390/ijms252413705. PMID:39769471. IF:4.900(Q1/3D).

de la Riva, P, Marta-Enguita, J, Rodríguez-Antigueedad, J, Bergareche, A, de Munain, AL. Understanding Endothelial Dysfunction and Its Role in Ischemic Stroke After the Outbreak of Recanalization Therapies. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(21)DOI:10.3390/ijms252111631. PMID:39519182. IF:4.900(Q1/3D).

Herrero-Lorenzo, M, Pérez-Pérez, J, Escaramís, G, Martínez-Horta, S, Pérez-González, R, Rivas-Asensio, E, Kulisevsky, J, Gámez-Valero, A, Martí, E. Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease. Journal of Extracellular Vesicles. 2024; 13(10)DOI:10.1002/jev2.12522. PMID:39377487. IF:14.500(Q1/1D).

Ruiz-Barrio, I, Vázquez-Oliver, A, Puig-Davi, A, Rivas-Asensio, E, Perez-Perez, J, Fernandez-Vizuete, C, Horta-Barba, A, Olmedo-Saura, G, Salvat-Rovira, N, Sampedro, F, Vacchi, E, Melli, G, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Skin Tau Quantification as a Novel Biomarker in Huntington's Disease. MOVEMENT DISORDERS. 2024; 39(11)DOI:10.1002/mds.29989. PMID:39192729. IF:7.600(Q1/1D).

Busteed, L, García-Sánchez, C, Pascual-Sedano, B, Grunden, N, Gironell, A, Kulisevsky, J, Pagonabarraga, J. Impact of Stimulation Frequency on Verbal Fluency Following Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY. 2024; DOI:10.1093/arclin/acae062. PMID:39127889. IF:2.100(Q2/5D).

Puig-Davi, A, Martinez-Horta, S, Pérez-Carasol, L, Horta-Barba, A, Ruiz-Barrio, I, Aracil-Bolaños, I, Pérez-González, R, Rivas-Asensio, E, Sampedro, F, Campolongo, A, Pagonabarraga, J, Kulisevsky, J. Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4-Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers. ANNALS OF NEUROLOGY. 2024; 96(5)DOI:10.1002/ana.27035. PMID:39099459. IF:7.700(Q1/1D).

Santos-Garcia, D, de Deus, T, Cores, C, Painceiras, MJF, Alvarado, MCI, Samaniego, LB, Maside, AL, Jesus, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Hernandez-Vara, J, Lopez, IC, Manzanares, LL, Gonzalez-Aramburu, I, Avila, A, Gomez-Mayordomo, V, Nogueira, V, Garcia-Soto, JD, Borrue-Fernandez, C, Solano, B, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Parees, I, Alonso, PS, Losada, MGA, Lopez-Ariztegui, N, Gaston, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Buongiorno, MT, Ordas, C, Menendez-Gonzalez, M, Mcafee, D, Martinez-Martin, P, Mir, P. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study. Movement Disorders Clinical Practice. 2024; 11(7)DOI:10.1002/mdc3.14056. PMID:38747234. IF:2.700(Q2/5D).

Gironell, A, Marín-Lahoz, J, Póveda, S. Essential Tremor: Update of Therapeutic Strategies. MEDICINA CLINICA. 2024; 162(12)DOI:10.1016/j.medcli.2023.12.013. PMID:38553256. IF:2.100(Q2/3D).

Dellarole, IL, Vacchi, E, Ruiz-Barrio, I, Pinton, S, Raimondi, A, Rossi, S, Morandi, S, Bianco, G, Bacinoglu, MB, Lombardo, A, Celauro, L, Staedler, C, Galati, S, Pagonabarraga, J, Kulisevsky, J, Legname, G, Gobbi, C, Kaelin-Lang, A, Moda, F, Melli, G. Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies. npj Parkinsons Disease. 2024; 10(1)DOI:10.1038/s41531-024-00728-9. PMID:38879633. IF:8.200(Q1/1D).

Kassubek, J, Factor, SA, Balaguer, E, Schwarz, J, Chaudhuri, KR, Isaacson, SH, Wu, S, Muhr, CD, Kulisevsky, J. Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study. JOURNAL OF NEUROLOGY. 2024; 271(6)DOI:10.1007/s00415-024-12323-2. PMID:38546829. IF:4.600(Q1/2D).

Martinez-Horta, S, Perez-Perez, J, Perez-Gonzalez, R, Sampedro, F, Horta-Barba, A, Campolongo, A, Rivas-Asensio, E, Puig-Davi, A, Pagonabarraga, J, Kulisevsky, J. Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease. Annals of Clinical and Translational Neurology. 2024; 11(5)DOI:10.1002/acn3.52031. PMID:38544341. IF:3.900(Q1/3D).

Garon, M, Weis, L, Siquier, A, Fiorenzato, E, Pistonesi, F, Cianci, V, Canesi, M, Pesce, F, Reali, E, Pozzi, B, Isaias, IU, Siri, C, Santangelo, G, Cuoco, S, Barone, P, Kulisevsky, J, Antonini, A, Biundo, R. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale. JOURNAL OF NEURAL TRANSMISSION. 2024; 131(4)DOI:10.1007/s00702-024-02746-6. PMID:38280057. IF:4.000(Q1/2D).

Pagonabarraga, J, Bejr-Kasem, H, Martinez-Horta, S, Kulisevsky, J. Parkinson disease psychosis: from phenomenology to neurobiological mechanisms. Nature Reviews Neurology. 2024; 20(3)DOI:10.1038/s41582-023-00918-8. PMID:38225264. IF:33.100(Q1/1D).

Ruiz-Barrio, I, Horta-Barba, A, Aracil-Bolaños, I, Martinez-Horta, S, Kulisevsky, J, Pagonabarraga, J. Predicting Disability in Progressive Supranuclear Palsy Using Bedside Frontal-Lobe Signs. Movement Disorders Clinical Practice. 2024; 11(3)DOI:10.1002/mdc3.13958. PMID:38164060. IF:2.700(Q2/5D).

Aracil-Bolaños, I, Pérez-Pérez, J, Martínez-Horta, S, Horta-Barba, A, Puig-Davi, A, Garcia-Cornet, J, Olmedo-Saura, G, Campolongo, A, Pagonabarraga, J, Kulisevsky, J. Baseline Large-Scale Network Dynamics Associated with Disease Progression in Huntington's Disease. MOVEMENT DISORDERS. 2024; 39(1)DOI:10.1002/mds.29655. PMID:38148511. IF:7.600(Q1/1D).

Rodríguez-Antigüedad J., Martínez-Horta S., Horta-Barba A., Puig-Davi A., Campolongo A., Sampedro F., Bejr-Kasem H., Marín-Lahoz J., Pagonabarraga J., Kulisevsky J.. Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease. JOURNAL OF NEURAL TRANSMISSION. 2024; 131(12)DOI:10.1007/s00702-023-02725-3. PMID:38206439. IF:4.000(Q1/2D).

Cattaneo, C, Kulisevsky, J. The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson's Disease. ADVANCES IN THERAPY. 2023; DOI:10.1007/s12325-023-02736-2. PMID:38070039. IF:3.400(Q2/3D).

Santos-García, D, Fonticoba, TD, Bartolomé, CC, Painceiras, MJF, Díaz, IG, Alvarado, MCI, Paz, JM, Jesús, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, García-Soto, JD, Borrué, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gastón, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Buongiorno, MT, Ordás, C, Menéndez-González, M, Mcafee, D, Martinez-Martin, P, Mir, P, COPPADIS Study Grp. Staging Parkinson's disease according to the MNCD classification correlates with caregiver burden. Brain and Behavior. 2023; 13(12)DOI:10.1002/brb3.3295. PMID:37939322. IF:2.600(Q2/3D).

Constantin VA, Szász JA, Dulamea AO, Valkovic P, Kulisevsky J. Impact of Infusion Therapies on Quality of Life in Advanced Parkinson's Disease.. Neuropsychiatric Disease and Treatment. 2023; 19DOI:10.2147/NDT.S422717. PMID:37727253. IF:2.500(Q2/5D).

Santos-García D., Cores Bartolomé C., Feal Painceiras M.J., García Díaz I., Íñiguez Alvarado M.C., Paz J.M., García Caldentey J., Hernández Vara J., Cabo I., López Manzanares L., González Aramburu I., Ávila Rivera M.A., Gómez Mayordomo V., Dotor García-Soto J., Borrué C., Solano Vila B., Álvarez Sauco M., Mendoza Z., Martínez Castrillo J.C., Sánchez Alonso P., Alonso Losada M.G., López Ariztegui N., Alonso Redondo R., Menéndez-González M., Adarmes A.D., Almeria M., Losada M.G.A., Cánovas A.A., Frech F.A., Redondo R.A., Álvarez I., Sauco M.Á., Díaz A.A., Arnáiz S., Arribas S., Vidondo A.A., Aguilar M., Ávila M.A., Lambrich N.N., Bejr-Kasem H., Estrada M.B., Botí M., Borrue C., Buongiorno M.T., González C.C., López I.C., Caballol N., Lorenzo A.C., Medina H.C., Pendón E.C., Carrillo F., Padilla F.J.C., Casas E., Catalán M.J., Clavero P., Fernández A.C., Cosgaya M., Foraster A.C., Cuevas A.C., Cubo E., de Deus Fonticoba T., de Fábregues-Boixar O., Díez-Fairen M., García-Soto J.D., Erro E., Escalante S., Peyret E.E., Guillán N.F., Gámez P., Gallego M., Caldentey J.G., Campos C.G., Díez C.G., Moreno J.M.G., Gastón I., Garre M.P.G., Mayordomo V.G., Aloy J.G., González-Aramburu I., Ardura J.G., García B.G., Palmás M.J.G., Toledo G.R.G., Díaz A.G., Solá M.G., Guardia G., Vara J.H., Horta-Barba A., Calderón D.I., Infante J., Jesús S., Kulisevsky J., Kurtis M., Labandeira C., Labrador M.A., Lacruz F., Castro M.L., Gómez S.L., Legarda I., Ariztegui N.L., Díaz L.M.L., Domínguez D.L., Manzanares L.L., Seoane B.L., del Pozo S.L., Macías Y., Mata M., Andres G.M., Martí M.J., Castrillo J.C.M., Martinez-Martin P., McAfee D., Meitín M.T., Plasencia Z.M., González M.M., del Barrio C.M., Mir P., Santiago J.M., Casado M.I.M., Diéguez A.M., García I.M., Nogueira V., Amado A.N., Ponte S.N., Ordás C., Pagonabarraga J., Pareés I., Pascual-Sedano B., Pastor P., Fuertes A.P., Noguera R.P., Planas-Ballvé A., Planellas L., Prats M.A., Jurczynska C.P., Puente V., Morlans M.P., Daví A.P., Rafales N.R., Méndez L.R., Pérez A.B.R., Roldán F., De Arcos M.R., Martínez J.R., Alonso P.S., Sánchez-Carpintero M., Díez G.S., Rodríguez A.S., Santacruz P., García D.S., Rodríguez J.C.S., Seijo M., Peña M.S., Vila B.S., Castro E.S., Tartari J.P., Valero C., Vargas L., Vela L., Villanueva C.. Cognitive impairment and dementia in young onset Parkinson’s disease. JOURNAL OF NEUROLOGY. 2023; DOI:10.1007/s00415-023-11921-w. PMID:37578489. IF:4.800(Q1/2D).

Horta-Barba, A, Martinez-Horta, S, Perez-Perez, J, Puig-Davi, A, de Lucia, N, de Michele, G, Salvatore, E, Kehrer, S, Priller, J, Migliore, S, Squitieri, F, Castaldo, A, Mariotti, C, Mananes, V, Lopez-Sendon, JL, Rodriguez, N, Martinez-Descals, A, Julio, F, Januaario, C, Delussi, M, de Tommaso, M, Noguera, S, Ruiz-Idiago, J, Sitek, EJ, Wallner, R, Nuzzi, A, Pagonabarraga, J, Kulisevsky, J. Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease: a comparison of assessment instruments. JOURNAL OF NEUROLOGY. 2023; 270(11)DOI:10.1007/s00415-023-11804-0. PMID:37462754. IF:4.800(Q1/2D).

Olszewska, DA, Shetty, A, Rajalingam, R, Rodriguez-Antiguedad, J, Hamed, M, Huang, JA, Breza, M, Rasheed, A, Bahr, N, Madoev, H, Westenberger, A, Trinh, J, Lohmann, K, Klein, C, Marras, C, Waln, O. Genotype-phenotype relations for episodic ataxia genes: MDSGene systematic review. EUROPEAN JOURNAL OF NEUROLOGY. 2023; 30(10)DOI:10.1111/ene.15969. PMID:37422902. IF:4.500(Q1/2D).

Kulisevsky J., Falup-Pecurariu C., Santens P., Jost W.H.. Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines. JOURNAL OF NEURAL TRANSMISSION. 2023; 130(11)DOI:10.1007/s00702-023-02664-z. PMID:37439943. IF:3.200(Q2/3D).

Collerton, D, Barnes, J, Diederich, NJ, Dudley, R, Ffytche, D, Friston, K, Goetz, CG, Goldman, JG, Jardri, R, Kulisevsky, J, Lewis, SJG, Naral, S, O'Callaghan, C, Onofrj, M, Pagonabarraga, J, Parr, T, Shine, JM, Stebbins, G, Taylor, JP, Tsuda, I, Weil, RS. Understanding visual hallucinations: A new synthesis. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2023; 150DOI:10.1016/j.neubiorev.2023.105208. PMID:37141962. IF:7.600(Q1/1D).

Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Gonzalez, JMP, Miro, CM, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LMLL, McAfee, D, Martinez-Martin, P, Mir, P. Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints. Journal of Clinical Neurology. 2023; 19(4)DOI:10.3988/jcn.2022.0186. PMID:36647231. IF:3.000(Q2/4D).

Collet-Vidiella, R, Olmedo-Saura, G, Ruiz-Barrio, I, Martinez-Viguera, A, Rodriguez-Santiago, B, Bernal, S, Kulisevsky, J, Pagonabarraga, J. Late-Onset Beta-Propeller Protein-Associated Neurodegeneration: A Case Report. Movement Disorders Clinical Practice. 2023; 10(8)DOI:10.1002/mdc3.13811. PMID:37635772. IF:2.600(Q2/5D).

Gironell, A. Essential tremor: are we just splitting hairs? Non-motor symptoms and essential tremor-plus. REVISTA DE NEUROLOGIA. 2023; 76(12)DOI:10.33588/rn.7612.2023083. PMID:37303101. IF:0.800(Q4/9D).

Horta-Barba A., Martinez-Horta S., Sampedro F., Pérez-Pérez J., Pagonabarraga J., Kulisevsky J.. Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington's disease. JOURNAL OF NEUROSCIENCE RESEARCH. 2023; 101(6)DOI:10.1002/jnr.25174. PMID:36807154. IF:2.900(Q2/5D).

Gamez, J, Calopa, M, Munoz, E, Ferre, A, Huertas, O, McAllister, K, Reig, N, Scart-Gres, C, Insa, R, Kulisevsky, J. A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2023; 89(5)DOI:10.1111/bcp.15635. PMID:36494329. IF:3.100(Q2/4D).